Galderma Investigational Site 8620

New York, New York 10025

0 studies enrolling now · 3 studies all time

What they study most

Acne Vulgaris, Moderate-to-Severe Atopic Dermatitis

Studies at this site

• Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis — Running, not enrolling
• Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis — Completed
• AkLief Evaluation in Acne-induced Post-Inflammatory Hyperpigmentation — Completed